NCT05965219View on ClinicalTrials.gov

A Trial to Evaluate the Effects of Itraconazole and Carbamazepine on the Pharmacokinetics of Emraclidine and of Emraclidine on the Pharmacokinetics of Metformin in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 15, 2023

Primary Completion Date

November 10, 2023

Study Completion Date

November 10, 2023

Conditions
Healthy Volunteers
Interventions
DRUG

Emraclidine

Emraclidine tablets.

DRUG

Itraconazole

Itraconazole oral solution.

DRUG

Carbamazepine

Carbamazepine tablets.

DRUG

Metformin

Metformin tablets.

Trial Locations (1)

66212

Overland Park, Kansas, Overland Park

Sponsors
All Listed Sponsors
lead

Cerevel Therapeutics, LLC

INDUSTRY

NCT05965219 - A Trial to Evaluate the Effects of Itraconazole and Carbamazepine on the Pharmacokinetics of Emraclidine and of Emraclidine on the Pharmacokinetics of Metformin in Healthy Adult Participants | Biotech Hunter | Biotech Hunter